 | • レポートコード：MRC2-11QY09118 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はライノウイルス感染症治療薬のグローバル市場について調査・分析したレポートです。種類別（塩化セチルピリジニウム、ヒトライノウイルス（多価）ワクチン、KR-22809、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ライノウイルス感染症治療薬の競争状況、市場シェア ・世界のライノウイルス感染症治療薬市場：種類別市場規模 2015年-2020年（塩化セチルピリジニウム、ヒトライノウイルス（多価）ワクチン、KR-22809、その他） ・世界のライノウイルス感染症治療薬市場：種類別市場規模予測 2021年-2026年（塩化セチルピリジニウム、ヒトライノウイルス（多価）ワクチン、KR-22809、その他） ・世界のライノウイルス感染症治療薬市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界のライノウイルス感染症治療薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米のライノウイルス感染症治療薬市場分析：米国、カナダ ・ヨーロッパのライノウイルス感染症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのライノウイルス感染症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のライノウイルス感染症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのライノウイルス感染症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AIMM Therapeutics B.V.、Biological Mimetics, Inc.、Biota Pharmaceuticals, Inc.、Boehringer Ingelheim GmbH、Johnson & Johnson、Novartis AG、Theraclone Sciences, Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Rhinovirus Infections Drug Market
The global Rhinovirus Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Rhinovirus Infections Drug Scope and Market Size
Rhinovirus Infections Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rhinovirus Infections Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Rhinovirus Infections Drug market is segmented into
Cetylpyridinium Chloride
Human Rhinovirus (polyvalent) Vaccine
KR-22809
Others
Segment by Application, the Rhinovirus Infections Drug market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The Rhinovirus Infections Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Rhinovirus Infections Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Rhinovirus Infections Drug Market Share Analysis
Rhinovirus Infections Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Rhinovirus Infections Drug business, the date to enter into the Rhinovirus Infections Drug market, Rhinovirus Infections Drug product introduction, recent developments, etc.
The major vendors covered:
AIMM Therapeutics B.V.
Biological Mimetics, Inc.
Biota Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
Johnson & Johnson
Novartis AG
Theraclone Sciences, Inc.
…
1 Study Coverage
1.1 Rhinovirus Infections Drug Product Introduction
1.2 Market Segments
1.3 Key Rhinovirus Infections Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Rhinovirus Infections Drug Market Size Growth Rate by Type
1.4.2 Cetylpyridinium Chloride
1.4.3 Human Rhinovirus (polyvalent) Vaccine
1.4.4 KR-22809
1.4.5 Others
1.5 Market by Application
1.5.1 Global Rhinovirus Infections Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Rhinovirus Infections Drug Market Size, Estimates and Forecasts
2.1.1 Global Rhinovirus Infections Drug Revenue 2015-2026
2.1.2 Global Rhinovirus Infections Drug Sales 2015-2026
2.2 Global Rhinovirus Infections Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Rhinovirus Infections Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Rhinovirus Infections Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Rhinovirus Infections Drug Competitor Landscape by Players
3.1 Rhinovirus Infections Drug Sales by Manufacturers
3.1.1 Rhinovirus Infections Drug Sales by Manufacturers (2015-2020)
3.1.2 Rhinovirus Infections Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Rhinovirus Infections Drug Revenue by Manufacturers
3.2.1 Rhinovirus Infections Drug Revenue by Manufacturers (2015-2020)
3.2.2 Rhinovirus Infections Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Rhinovirus Infections Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Rhinovirus Infections Drug Revenue in 2019
3.2.5 Global Rhinovirus Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Rhinovirus Infections Drug Price by Manufacturers
3.4 Rhinovirus Infections Drug Manufacturing Base Distribution, Product Types
3.4.1 Rhinovirus Infections Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Rhinovirus Infections Drug Product Type
3.4.3 Date of International Manufacturers Enter into Rhinovirus Infections Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Rhinovirus Infections Drug Market Size by Type (2015-2020)
4.1.1 Global Rhinovirus Infections Drug Sales by Type (2015-2020)
4.1.2 Global Rhinovirus Infections Drug Revenue by Type (2015-2020)
4.1.3 Rhinovirus Infections Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Rhinovirus Infections Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Rhinovirus Infections Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Rhinovirus Infections Drug Revenue Forecast by Type (2021-2026)
4.2.3 Rhinovirus Infections Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Rhinovirus Infections Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Rhinovirus Infections Drug Market Size by Application (2015-2020)
5.1.1 Global Rhinovirus Infections Drug Sales by Application (2015-2020)
5.1.2 Global Rhinovirus Infections Drug Revenue by Application (2015-2020)
5.1.3 Rhinovirus Infections Drug Price by Application (2015-2020)
5.2 Rhinovirus Infections Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Rhinovirus Infections Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Rhinovirus Infections Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Rhinovirus Infections Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Rhinovirus Infections Drug by Country
6.1.1 North America Rhinovirus Infections Drug Sales by Country
6.1.2 North America Rhinovirus Infections Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Rhinovirus Infections Drug Market Facts & Figures by Type
6.3 North America Rhinovirus Infections Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Rhinovirus Infections Drug by Country
7.1.1 Europe Rhinovirus Infections Drug Sales by Country
7.1.2 Europe Rhinovirus Infections Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Rhinovirus Infections Drug Market Facts & Figures by Type
7.3 Europe Rhinovirus Infections Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Rhinovirus Infections Drug by Region
8.1.1 Asia Pacific Rhinovirus Infections Drug Sales by Region
8.1.2 Asia Pacific Rhinovirus Infections Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Rhinovirus Infections Drug Market Facts & Figures by Type
8.3 Asia Pacific Rhinovirus Infections Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Rhinovirus Infections Drug by Country
9.1.1 Latin America Rhinovirus Infections Drug Sales by Country
9.1.2 Latin America Rhinovirus Infections Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Rhinovirus Infections Drug Market Facts & Figures by Type
9.3 Central & South America Rhinovirus Infections Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Rhinovirus Infections Drug by Country
10.1.1 Middle East and Africa Rhinovirus Infections Drug Sales by Country
10.1.2 Middle East and Africa Rhinovirus Infections Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Rhinovirus Infections Drug Market Facts & Figures by Type
10.3 Middle East and Africa Rhinovirus Infections Drug Market Facts & Figures by Application
11 Company Profiles
11.1 AIMM Therapeutics B.V.
11.1.1 AIMM Therapeutics B.V. Corporation Information
11.1.2 AIMM Therapeutics B.V. Description and Business Overview
11.1.3 AIMM Therapeutics B.V. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AIMM Therapeutics B.V. Rhinovirus Infections Drug Products Offered
11.1.5 AIMM Therapeutics B.V. Related Developments
11.2 Biological Mimetics, Inc.
11.2.1 Biological Mimetics, Inc. Corporation Information
11.2.2 Biological Mimetics, Inc. Description and Business Overview
11.2.3 Biological Mimetics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biological Mimetics, Inc. Rhinovirus Infections Drug Products Offered
11.2.5 Biological Mimetics, Inc. Related Developments
11.3 Biota Pharmaceuticals, Inc.
11.3.1 Biota Pharmaceuticals, Inc. Corporation Information
11.3.2 Biota Pharmaceuticals, Inc. Description and Business Overview
11.3.3 Biota Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Products Offered
11.3.5 Biota Pharmaceuticals, Inc. Related Developments
11.4 Boehringer Ingelheim GmbH
11.4.1 Boehringer Ingelheim GmbH Corporation Information
11.4.2 Boehringer Ingelheim GmbH Description and Business Overview
11.4.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Boehringer Ingelheim GmbH Rhinovirus Infections Drug Products Offered
11.4.5 Boehringer Ingelheim GmbH Related Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Description and Business Overview
11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Johnson & Johnson Rhinovirus Infections Drug Products Offered
11.5.5 Johnson & Johnson Related Developments
11.6 Novartis AG
11.6.1 Novartis AG Corporation Information
11.6.2 Novartis AG Description and Business Overview
11.6.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis AG Rhinovirus Infections Drug Products Offered
11.6.5 Novartis AG Related Developments
11.7 Theraclone Sciences, Inc.
11.7.1 Theraclone Sciences, Inc. Corporation Information
11.7.2 Theraclone Sciences, Inc. Description and Business Overview
11.7.3 Theraclone Sciences, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Theraclone Sciences, Inc. Rhinovirus Infections Drug Products Offered
11.7.5 Theraclone Sciences, Inc. Related Developments
11.1 AIMM Therapeutics B.V.
11.1.1 AIMM Therapeutics B.V. Corporation Information
11.1.2 AIMM Therapeutics B.V. Description and Business Overview
11.1.3 AIMM Therapeutics B.V. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AIMM Therapeutics B.V. Rhinovirus Infections Drug Products Offered
11.1.5 AIMM Therapeutics B.V. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Rhinovirus Infections Drug Market Estimates and Projections by Region
12.1.1 Global Rhinovirus Infections Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Rhinovirus Infections Drug Revenue Forecast by Regions 2021-2026
12.2 North America Rhinovirus Infections Drug Market Size Forecast (2021-2026)
12.2.1 North America: Rhinovirus Infections Drug Sales Forecast (2021-2026)
12.2.2 North America: Rhinovirus Infections Drug Revenue Forecast (2021-2026)
12.2.3 North America: Rhinovirus Infections Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Rhinovirus Infections Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Rhinovirus Infections Drug Sales Forecast (2021-2026)
12.3.2 Europe: Rhinovirus Infections Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Rhinovirus Infections Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Rhinovirus Infections Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Rhinovirus Infections Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Rhinovirus Infections Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Rhinovirus Infections Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Rhinovirus Infections Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Rhinovirus Infections Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Rhinovirus Infections Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Rhinovirus Infections Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Rhinovirus Infections Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Rhinovirus Infections Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Rhinovirus Infections Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Rhinovirus Infections Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Rhinovirus Infections Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Rhinovirus Infections Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Rhinovirus Infections Drug Market Segments
Table 2. Ranking of Global Top Rhinovirus Infections Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Rhinovirus Infections Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Cetylpyridinium Chloride
Table 5. Major Manufacturers of Human Rhinovirus (polyvalent) Vaccine
Table 6. Major Manufacturers of KR-22809
Table 7. Major Manufacturers of Others
Table 8. Global Rhinovirus Infections Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Rhinovirus Infections Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Rhinovirus Infections Drug Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Rhinovirus Infections Drug Sales Market Share by Regions (2015-2020)
Table 12. Global Rhinovirus Infections Drug Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Rhinovirus Infections Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Rhinovirus Infections Drug Sales Share by Manufacturers (2015-2020)
Table 15. Global Rhinovirus Infections Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Rhinovirus Infections Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rhinovirus Infections Drug as of 2019)
Table 17. Rhinovirus Infections Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Rhinovirus Infections Drug Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Rhinovirus Infections Drug Price (2015-2020) (USD/Pcs)
Table 20. Rhinovirus Infections Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Rhinovirus Infections Drug Product Type
Table 22. Date of International Manufacturers Enter into Rhinovirus Infections Drug Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Rhinovirus Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 25. Global Rhinovirus Infections Drug Sales Share by Type (2015-2020)
Table 26. Global Rhinovirus Infections Drug Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Rhinovirus Infections Drug Revenue Share by Type (2015-2020)
Table 28. Rhinovirus Infections Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Rhinovirus Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 30. Global Rhinovirus Infections Drug Sales Share by Application (2015-2020)
Table 31. North America Rhinovirus Infections Drug Sales by Country (2015-2020) (K Pcs)
Table 32. North America Rhinovirus Infections Drug Sales Market Share by Country (2015-2020)
Table 33. North America Rhinovirus Infections Drug Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Rhinovirus Infections Drug Revenue Market Share by Country (2015-2020)
Table 35. North America Rhinovirus Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 36. North America Rhinovirus Infections Drug Sales Market Share by Type (2015-2020)
Table 37. North America Rhinovirus Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 38. North America Rhinovirus Infections Drug Sales Market Share by Application (2015-2020)
Table 39. Europe Rhinovirus Infections Drug Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Rhinovirus Infections Drug Sales Market Share by Country (2015-2020)
Table 41. Europe Rhinovirus Infections Drug Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Rhinovirus Infections Drug Revenue Market Share by Country (2015-2020)
Table 43. Europe Rhinovirus Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Rhinovirus Infections Drug Sales Market Share by Type (2015-2020)
Table 45. Europe Rhinovirus Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Rhinovirus Infections Drug Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Rhinovirus Infections Drug Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Rhinovirus Infections Drug Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Rhinovirus Infections Drug Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Rhinovirus Infections Drug Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Rhinovirus Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Rhinovirus Infections Drug Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Rhinovirus Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Rhinovirus Infections Drug Sales Market Share by Application (2015-2020)
Table 55. Latin America Rhinovirus Infections Drug Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Rhinovirus Infections Drug Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Rhinovirus Infections Drug Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Rhinovirus Infections Drug Revenue Market Share by Country (2015-2020)
Table 59. Latin America Rhinovirus Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Rhinovirus Infections Drug Sales Market Share by Type (2015-2020)
Table 61. Latin America Rhinovirus Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Rhinovirus Infections Drug Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Rhinovirus Infections Drug Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Rhinovirus Infections Drug Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Rhinovirus Infections Drug Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Rhinovirus Infections Drug Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Rhinovirus Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Rhinovirus Infections Drug Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Rhinovirus Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Rhinovirus Infections Drug Sales Market Share by Application (2015-2020)
Table 71. AIMM Therapeutics B.V. Corporation Information
Table 72. AIMM Therapeutics B.V. Description and Major Businesses
Table 73. AIMM Therapeutics B.V. Rhinovirus Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. AIMM Therapeutics B.V. Product
Table 75. AIMM Therapeutics B.V. Recent Development
Table 76. Biological Mimetics, Inc. Corporation Information
Table 77. Biological Mimetics, Inc. Description and Major Businesses
Table 78. Biological Mimetics, Inc. Rhinovirus Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Biological Mimetics, Inc. Product
Table 80. Biological Mimetics, Inc. Recent Development
Table 81. Biota Pharmaceuticals, Inc. Corporation Information
Table 82. Biota Pharmaceuticals, Inc. Description and Major Businesses
Table 83. Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Biota Pharmaceuticals, Inc. Product
Table 85. Biota Pharmaceuticals, Inc. Recent Development
Table 86. Boehringer Ingelheim GmbH Corporation Information
Table 87. Boehringer Ingelheim GmbH Description and Major Businesses
Table 88. Boehringer Ingelheim GmbH Rhinovirus Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Boehringer Ingelheim GmbH Product
Table 90. Boehringer Ingelheim GmbH Recent Development
Table 91. Johnson & Johnson Corporation Information
Table 92. Johnson & Johnson Description and Major Businesses
Table 93. Johnson & Johnson Rhinovirus Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Johnson & Johnson Product
Table 95. Johnson & Johnson Recent Development
Table 96. Novartis AG Corporation Information
Table 97. Novartis AG Description and Major Businesses
Table 98. Novartis AG Rhinovirus Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Novartis AG Product
Table 100. Novartis AG Recent Development
Table 101. Theraclone Sciences, Inc. Corporation Information
Table 102. Theraclone Sciences, Inc. Description and Major Businesses
Table 103. Theraclone Sciences, Inc. Rhinovirus Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Theraclone Sciences, Inc. Product
Table 105. Theraclone Sciences, Inc. Recent Development
Table 106. Global Rhinovirus Infections Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 107. Global Rhinovirus Infections Drug Sales Market Share Forecast by Regions (2021-2026)
Table 108. Global Rhinovirus Infections Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 109. Global Rhinovirus Infections Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 110. North America: Rhinovirus Infections Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 111. North America: Rhinovirus Infections Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Europe: Rhinovirus Infections Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 113. Europe: Rhinovirus Infections Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Asia Pacific: Rhinovirus Infections Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 115. Asia Pacific: Rhinovirus Infections Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 116. Latin America: Rhinovirus Infections Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. Latin America: Rhinovirus Infections Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Middle East and Africa: Rhinovirus Infections Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Middle East and Africa: Rhinovirus Infections Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 121. Key Challenges
Table 122. Market Risks
Table 123. Main Points Interviewed from Key Rhinovirus Infections Drug Players
Table 124. Rhinovirus Infections Drug Customers List
Table 125. Rhinovirus Infections Drug Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Rhinovirus Infections Drug Product Picture
Figure 2. Global Rhinovirus Infections Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Cetylpyridinium Chloride Product Picture
Figure 4. Human Rhinovirus (polyvalent) Vaccine Product Picture
Figure 5. KR-22809 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Rhinovirus Infections Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Clinic
Figure 9. Hospital
Figure 10. Others
Figure 11. Rhinovirus Infections Drug Report Years Considered
Figure 12. Global Rhinovirus Infections Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Rhinovirus Infections Drug Sales 2015-2026 (K Pcs)
Figure 14. Global Rhinovirus Infections Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Rhinovirus Infections Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Rhinovirus Infections Drug Sales Market Share by Region in 2019
Figure 17. Global Rhinovirus Infections Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Rhinovirus Infections Drug Revenue Market Share by Region in 2019
Figure 19. Global Rhinovirus Infections Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Rhinovirus Infections Drug Revenue in 2019
Figure 21. Rhinovirus Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Rhinovirus Infections Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Rhinovirus Infections Drug Sales Market Share by Type in 2019
Figure 24. Global Rhinovirus Infections Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Rhinovirus Infections Drug Revenue Market Share by Type in 2019
Figure 26. Global Rhinovirus Infections Drug Market Share by Price Range (2015-2020)
Figure 27. Global Rhinovirus Infections Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Rhinovirus Infections Drug Sales Market Share by Application in 2019
Figure 29. Global Rhinovirus Infections Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Rhinovirus Infections Drug Revenue Market Share by Application in 2019
Figure 31. North America Rhinovirus Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Rhinovirus Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Rhinovirus Infections Drug Sales Market Share by Country in 2019
Figure 34. North America Rhinovirus Infections Drug Revenue Market Share by Country in 2019
Figure 35. U.S. Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Rhinovirus Infections Drug Market Share by Type in 2019
Figure 40. North America Rhinovirus Infections Drug Market Share by Application in 2019
Figure 41. Europe Rhinovirus Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Rhinovirus Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Rhinovirus Infections Drug Sales Market Share by Country in 2019
Figure 44. Europe Rhinovirus Infections Drug Revenue Market Share by Country in 2019
Figure 45. Germany Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Rhinovirus Infections Drug Market Share by Type in 2019
Figure 56. Europe Rhinovirus Infections Drug Market Share by Application in 2019
Figure 57. Asia Pacific Rhinovirus Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Rhinovirus Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Rhinovirus Infections Drug Sales Market Share by Region in 2019
Figure 60. Asia Pacific Rhinovirus Infections Drug Revenue Market Share by Region in 2019
Figure 61. China Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Rhinovirus Infections Drug Market Share by Type in 2019
Figure 84. Asia Pacific Rhinovirus Infections Drug Market Share by Application in 2019
Figure 85. Latin America Rhinovirus Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Rhinovirus Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Rhinovirus Infections Drug Sales Market Share by Country in 2019
Figure 88. Latin America Rhinovirus Infections Drug Revenue Market Share by Country in 2019
Figure 89. Mexico Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Rhinovirus Infections Drug Market Share by Type in 2019
Figure 96. Latin America Rhinovirus Infections Drug Market Share by Application in 2019
Figure 97. Middle East and Africa Rhinovirus Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Rhinovirus Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Rhinovirus Infections Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Rhinovirus Infections Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Rhinovirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Rhinovirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Rhinovirus Infections Drug Market Share by Type in 2019
Figure 108. Middle East and Africa Rhinovirus Infections Drug Market Share by Application in 2019
Figure 109. North America Rhinovirus Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Rhinovirus Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Rhinovirus Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Rhinovirus Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Rhinovirus Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Rhinovirus Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Rhinovirus Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Rhinovirus Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Rhinovirus Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Rhinovirus Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
類鼻疽菌感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Burkholderia Pseudomallei Infections Drug Market The global Burkholderia Pseudomallei Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Burkholderia Pseudomallei Infec…- ロタウイルス感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Rotavirus Infections Drug Market The global Rotavirus Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rotavirus Infections Drug Scope and Market Size Rotavirus Infec…
- 髄膜炎菌感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Neisseria meningitidis Infections Drug Market The global Neisseria meningitidis Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Neisseria meningitidis Infections Dru…
- A型インフルエンザウイルス・H3N2亜型感染症薬の世界市場（～2026年） Market Analysis and Insights: Global Influenza A Virus, H3N2 Subtype Infections Drug Market The global Influenza A Virus, H3N2 Subtype Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Influenza A Virus, …
- 医療関連感染（HAI）診断の世界市場（～2026年） Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections. The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric populati…